Showing 1 - 10 of 1,605
We study how risk management through hedging impacts firms and competition among firms in the life insurance industry - an industry with over 7 Trillion in assets and over 1,000 private and public firms. We show that firms that are likely to face costly external finance increase hedging after...
Persistent link: https://www.econbiz.de/10012585845
The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...
Persistent link: https://www.econbiz.de/10012959215
We examine the extent of operational and financial hedging in US oil and gas companies. Using a combination of hand collected and publicly available data we first calculate financial and commodity exposure. We find significant exposure to underlying commodity movements. We find no evidence that...
Persistent link: https://www.econbiz.de/10012962900
Deregulation of the trucking industry and significantly lowered transportation costs led to large, widespread, and plausibly exogenous reductions in inventory for U.S. firms, but with consequent increased supply chain disruption costs. We find evidence that increased supply chain disruption...
Persistent link: https://www.econbiz.de/10012973533
Derivatives are financial instruments that are mainly used to protect against and manage risks, very often also serve arbitrage or investment purpose, provides various advantages compared to securities. Derivatives are various types and can differentiated by how they are traded, the underlying...
Persistent link: https://www.econbiz.de/10013055542
Purpose – This study develops a non-traditional measure of risk, an Exposure-Based Volatility, for the non-financial company and applies this measure to capture both the downside potential of cash flows and the probability of requiring additional external financing under most foreseeable...
Persistent link: https://www.econbiz.de/10012991529
The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...
Persistent link: https://www.econbiz.de/10011749446
We consider a dynamic model of investment in which a firm can hold inventory to mitigate the price risk of an input commodity. Our model predicts that inventory allows to hedge against net worth risk by smoothing investment in capital, irrespective of the level of current net worth. Savings...
Persistent link: https://www.econbiz.de/10011659522
We propose and model that firms face two potential defaults: Financial default on their debt obligations and operational default such as a failure to deliver on obligations to customers. Hence, firms with limitations on outside financing substitute between saving cash for financial hedging to...
Persistent link: https://www.econbiz.de/10014359303
We characterize a firm as a nexus of activities and projects with their associated cashflow distributions across states of the world and time. With specialized managers intent on maximizing firm value, we show that such a representation leads to a transformation possibility frontier between the...
Persistent link: https://www.econbiz.de/10008617033